| Titre : | Addiction, Vol.113, n°7 - July 2018 |
| Type de document : | Bulletin : Périodique |
| Paru le : | 01/07/2018 |
| Année de publication : | 2018 |
| Format : | 1173-1376 |
| Langues: | Anglais |
| Note de contenu : |
CONTENTS:
- Fulfilling the promise of choice architecture interventions for addictive behaviors [Editorial]. Tucker J.A., p. 1175-1177. - The need to exercise caution in accepting addiction as a reason for performing euthanasia [Addiction debate]. Hall W., Parker M., p. 1178-1180. - Euthanasia for what? Attending to the role of stigma in addiction-related 'intractable suffering' and 'incurability'. Seear K., Fraser S., p. 1181-1182. - Euthanasia and the nature of suffering in addiction. Ashcroft R.E., p. 1183-1184. - Euthanasia and addiction: a comment from the Netherlands. Boer T., p. 1184-1185. - Important patient and public (PPI) perspectives on addiction as a reason for performing euthanasia. Irving A., p. 1185-1186. - Reasons for ambivalence about accepting addiction as a reason for performing euthanasia. Hall W., Parker M., p. 1186-1187. - Extended-release injectable naltrexone for opioid use disorder: a systematic review. Jarvis B.P., Holtyn A.F., Subramaniam S., Tompkins D.A., Oga E.A., Bigelow G.E., et al., p. 1188-1209. - The future of the international drug control system and national drug prohibitions. Hall W., p. 1210-1223. - In praise of flawed treaties. Caulkins J.P., p. 1224-1225. - From failed global drug prohibition to regulating the drug market. Wodak A., p. 1225-1226. - Canada, cannabis legalization and uncertainty around the United Nations drug control conventions. Bewley-Taylor D.R., p. 1226-1228. - The international drug conventions continue to provide a flexible framework to address the drug problem. Carpentier C., Niaz K., Tettey J., p. 1228-1229. - Imperfect international treaties interpreted flexibly are likely to be better than no treaties. Hall W., p. 1230. - Unrecorded alcohol use: a global modelling study based on nominal group assessments and survey data. Probst C., Manthey J., Merey A., Rylett M., Rehm J., p. 1231-1241. - Commentary on Probst et al. (2018): Unrecorded alcohol use-an underestimated global phenomenon. Lachenmeier D.W., Walch S.G., p. 1242-1243. - Impacts of licensed premises trading hour policies on alcohol-related harms. Atkinson J.A., Prodan A., Livingston M., Knowles D., O'Donnell E., Room R., et al., p. 1244-1251. - Alcohol, pattern of drinking and all-cause mortality in Russia, Belarus and Hungary: a retrospective indirect cohort study based on mortality of relatives. Horvat P., Stefler D., Murphy M., King L., McKee M., Bobak M., p. 1252-1263. - Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial. Bansback N., Guh D., Oviedo-Joekes E., Brissette S., Harrison S., Janmohamed A., et al., p. 1264-1273. - Commentary on Bansback et al. (2018): Estimating the cost of stigma against injection. Linas B.P., p. 1274-1275. - The relationship between methamphetamine use and heterosexual behaviour: evidence from a prospective longitudinal study. McKetin R., Lubman D.I., Baker A., Dawe S., Ross J., Mattick R.P., et al., p. 1276-1285. - Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway. Nechanska B., Mravcik V., Skurtveit S., Lund I.O., Gabrhelik R., Engeland A., et al., p. 1286-1294. - Do predictors of smoking relapse change as a function of duration of abstinence? Findings from the United States, Canada, United Kingdom and Australia. Yong H.H., Borland R., Cummings K.M., Partos T., p. 1295-1304. - Estimating the health-care costs of children born to pregnant smokers in England: cohort study using primary and secondary health-care data. Vaz L.R., Jones M.J., Szatkowski L., Tata L.J., Petrou S., Coleman T., p. 1305-1316. - 'Are The Times A-Changin'? Trends in adolescent substance use in Europe. Kraus L., Seitz N.N., Piontek D., Molinaro S., Siciliano V., Guttormsson U., et al., p. 1317-1332. - Investigating causal associations between use of nicotine, alcohol, caffeine and cannabis: a two-sample bidirectional Mendelian randomization study. Verweij K.J.H., Treur J.L., Vink J.M., p. 1333-1338. - Corrected US opioid-involved drug poisoning deaths and mortality rates, 1999-2015. Ruhm C.J., p. 1339-1344. - 'Addressed to you not as a smoker... but as a doctor': doctor-targeted cigarette advertisements in JAMA. Jackler R.K., Ayoub N.F., p. 1345-1363. - Commentary on Jackler & Ayoub (2018): Doctor-targeted cigarette advertisements and conflicts of interest in historical context. Gardner M.N., p. 1364-1365. |
| Cote : | Abonnement |
| Lien : | https://onlinelibrary.wiley.com/toc/13600443/2018/113/7 |
Dépouillements
Ajouter le résultat dans votre panierArticle : Périodique
A major impediment to any nation abandoning the policy of drug prohibition has been the fact that international drug treaties to which the majority of United Nations (UN) member states are signatory prohibit the non-medical use of amphetamines, [...]
Article : Périodique
L. KRAUS ;
N. N. SEITZ ;
D. PIONTEK ;
S. MOLINARO ;
V. SICILIANO ;
U. GUTTORMSSON ;
S. ARPA ;
K. MONSHOUWER ;
H. LEIFMAN ;
J. VICENTE ;
P. GRIFFITHS ;
L. CLANCY ;
F. FEIJAO ;
S. FLORESCU ;
P. LAMBRECHT ;
A. NOCIAR ;
K. RAITASALO ;
S. SPILKA ;
K. VYSHINSKIY ;
B. HIBELL
|
AIMS: To estimate temporal trends in adolescents' current cigarette, alcohol and cannabis use in Europe by gender and region, test for regional differences and evaluate regional convergence.
DESIGN AND SETTING: Five waves of the European School[...]
Article : Périodique
BACKGROUND AND AIMS: Most prior estimates of opioid-involved drug poisoning mortality counts or rates are understated because the specific drugs leading to death are frequently not identified on death certificates. This analysis provides correct[...]
Exemplaires
| Disponibilité |
|---|
| aucun exemplaire |
Accueil
